On Gestagen Treatment of Advanced Prostatic Carcinoma
- 1 January 1978
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 12 (2) , 119-121
- https://doi.org/10.3109/00365597809179977
Abstract
Depostat treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy.Keywords
This publication has 9 references indexed in Scilit:
- Androgen Receptors in the Anterior Pituitary and Central Nervous System of the Androgen “Insensitive” (Tfm) Rat: Correlation Between Receptor Binding and Effects of Androgens on Gonadotropin SecretionEndocrinology, 1976
- Mode of action of progesterone, gestonorone capronate (depostat) and cyproterone acetate (androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigationsJournal of Steroid Biochemistry, 1975
- DEXTRAN-COATED CHARCOAL USED IN THE RADIOIMMUNOASSAY OF HUMAN PITUITARY LUTEINIZING HORMONEActa Endocrinologica, 1973
- Experience in the Treatment of Prostatic Carcinoma with Cyproterone AcetateJournal of Urology, 1973
- STEROID DETERMINATIONS IN SIX CASES OF HYPERPLASIA AND THREE CASES OF TUMOUR OF THE ADRENAL CORTEXActa Medica Scandinavica, 1968
- Treatment of Benign Prostatic Hypertrophy With Hydroxyprogesterone CaproatePublished by American Medical Association (AMA) ,1965
- A METHOD FOR THE ANALYSIS OF URINARY 17-HYDROXYCORTICOSTEROIDSJournal of Endocrinology, 1961
- ASSESSMENT OF ADRENOCORTICAL ACTIVITY BY ASSAY OF 17-KETOGENIC STEROIDS IN URINEThe Lancet, 1953
- ENDOCRINE CONTROL OF PROSTATIC CARCINOMAJAMA, 1950